COMPANY

GMJ Technologies, Inc.

We are developing robust technologies that enhance productivity for researchers in all stages of biopharmaceutical developments and proteomics. From company website Source · Oct 13, 2026

Keywords: proteomics

Location: Seattle, WA · source · Oct 13, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $902K (SBIR Phase II 5R44GM156142-03, continuation, notice May 12, 2026). NIH RePORTER 5R44GM156142-03 (May 12, 2026)
Evidence (1 event)
- May 12, 2026 · NIH RePORTER 5R44GM156142-03
  Organization: GMJ TECHNOLOGIES, INC.; City/State: EVERETT, WA; Project number: 5R44GM156142-03; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-05-12; FY total cost (award amount): 902099; Administering IC: National Institute of General Medical Sciences; Project title: High-Resolution Native Capillary Zone Electrophoresis with Inline UV and Native Mass Spectrometry for Characterizing Charge Variants in Biologics; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Timeline

May 12, 2026 Grant Government grant — SBIR: $902,099 (annual award, as published), announced May 12, 2026. Agency: NIH/NIGMS. Source: government award database. source ↗
Apr 28, 2025 Grant Government grant — SBIR: $1.6M (annual award, as published), announced Apr 28, 2025. Agency: NIH/NIGMS. Source: government award database. source ↗

Funding

Last 2 years.

May 12, 2026 Government grant — SBIR: $902,099 (annual award, as published), announced May 12, 2026. Agency: NIH/NIGMS. Source: government award database. source ↗
Apr 28, 2025 Government grant — SBIR: $1.6M (annual award, as published), announced Apr 28, 2025. Agency: NIH/NIGMS. Source: government award database. source ↗